Browse by:
Research & Development

Waters Corp. names new CEO

Christopher J. O'Connell will take on the role of chief executive officer at Waters Corp. beginning in September.

Ocata Therapeutics prices $30 million common stock offering

Sam Bonacci |

Marlborough's Ocata Therapeutics is expecting to net over $30 million in a stock offering, after the company announced pricing for the stock Wednesday.

Philips to move operations from N.Y. to Cambridge

Sam Bonacci |

The international lighting company Royal Philips, which has operations in Framingham, has signed a $25 million research agreement with MIT and will move its North American research center from New...

NIH funds WPI heart valve study

Carol McDonald |

Research at Worcester Polytechnic Institute aimed at creating more natural and durable replacement heart valves is getting a boost from the National Institutes of Health, the school announced...

AMSC stock soars following likely Navy deal

Sam Bonacci |

Stock in Devens-based AMSC shot up more than 30 percent this week after the company announced expanded relationships with both the U.S. Navy and energy provider Eversource.

Oxford Immunotec launches T cell test

Oxford Immunotec of Marlborough has developed a laboratory test that measures a patient's immunity to cytomegalovirus (CMV), a herpes virus.

Q&A with Anne Hardy, Director, Saint-Gobain Research and Development Center

Rick Saia |

Anne Hardy was recently honored by The Manufacturing Institute with its Women in Manufacturing STEP (science, technology, engineering and production) Award. The award honors women across...

RXi grows 4Q revenue, cuts losses

RXi Pharmaceuticals of Marlborough, which is pushing toward federal approval of its initial products, saw 8.3-percent revenue growth in the final quarter of 2014 while paring its quarterly loss over...

New England Peptide to expand in Gardner

Sam Bonacci |

Biomedical firm New England Peptide (NEP) will expand its Gardner facility to create additional research and production space, the company announced Tuesday.

Warren: U.S. research fund cuts could be 'real problem'

STATE HOUSE NEWS SERVICE |

Massachusetts is vulnerable to cuts in federal funding for medical, scientific and engineering research under a Republican-controlled Congress, according to Sen. Elizabeth Warren.

ADVERTISEMENTS
Copyright 2015 New England Business Media